甲状腺髓样癌患者颈外侧淋巴结转移危险因素分析

doi:10.3724/zdxbyxb-2021-0210

浙江大学学报（医学版）

2021, Vol. 50

Issue (6): 730-740 DOI: 10.3724/zdxbyxb-2021-0210

专题报道

甲状腺髓样癌患者颈外侧淋巴结转移危险因素分析

吴凡¹,周天晗¹,陆凯宁²,潘婷¹,倪烨钦²,赵玲倩¹,姜可成¹,张煜²,罗定存^2,*(

)

1.浙江中医药大学第四临床医学院，浙江杭州 310053
2.浙江大学医学院附属杭州市第一人民医院肿瘤外科，浙江杭州 310003

Risk factors for lateral cervical lymph node metastasis in medullary thyroid carcinoma

WU Fan¹,ZHOU Tianhan¹,LU Kaining²,PAN Ting¹,NI Yeqin²,ZHAO Lingqian¹,JIANG Kecheng¹,ZHANG Yu²,LUO Dingcun^2,*(

)

1. The Fourth Clinical Medicine College, Zhejiang Chinese Medical University, Hangzhou 310053, China;
2. Department of Surgical Oncology, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China

全文: PDF(3214 KB)

HTML( 2 )

摘要：

目的：探讨影响甲状腺髓样癌（MTC）患者颈外侧转移性淋巴结的临床及超声影像危险因素。方法：检索PubMed、Web of Science、Embase、Cochrane、万方数据和中国知网等数据库收录的关于MTC患者颈外侧转移性淋巴结危险因素的相关文献，按照纳入和排除标准筛选文献，经质量评价后采用Stata?14.0软件进行meta分析。根据样本量、范围、中位数和四分位数间距估计均值和标准差，利用固定效应模型或随机效应模型计算各变量比值比（OR）或标准化均数差（SMD）及两者95%置信区间（CI），采用Egger法和Begg法评估文献发表偏倚。研究已在PROSPERO注册（CRD42021254955）。结果：最终纳入15篇文献，共有患者1424例，发生颈外侧淋巴结转移543例（38.13%）。Meta分析结果显示，男性（OR=1.64，95%CI：1.29~2.09，Z=4.06，P<0.01），肿瘤直径不小于1?cm（OR=5.09，95%CI：2.43~10.67，Z=4.31，P<0.01），肿瘤多灶性（OR=2.55，95%CI：1.79~3.61，Z=5.22，P<0.01），肿瘤被膜侵犯（OR=7.80，95%CI：4.84~12.55，Z=8.46，P<0.01），肿瘤腺外侵犯（OR=9.46，95%CI：5.66~15.81，Z=8.58，P<0.01），转移性颈部中央淋巴结（简称中央淋巴结）（OR=23.58，95%CI：9.44~58.87，Z=6.77，P<0.01），术前降钙素水平升高（SMD=1.17，95%CI：0.67~1.67，Z=4.56，P<0.01），超声下病灶边缘不光整（OR=4.32，95%CI：2.43~7.68，Z=4.99，P<0.01）及超声下病灶形态不规则（OR=6.81，95%CI：3.64~12.73，Z=6.01，P<0.01）是MTC患者发生颈外侧淋巴结转移的危险因素，而年龄不小于45岁（OR=1.22，95%CI：0.65~2.29，Z=0.62，P>0.05），术前癌胚抗原水平升高（SMD=0.95，95%CI：–0.48~2.38，Z=1.30，P>0.05）以及超声下钙化（OR=1.28，95%CI：0.75~2.18，Z=0.92，P>0.05）与MTC患者颈外侧转移性淋巴结无明显相关性。结论：男性、肿瘤直径不小于1?cm、肿瘤多灶性、肿瘤被膜侵犯、肿瘤腺外侵犯、转移性中央淋巴结、术前降钙素水平升高、超声下病灶边缘不光整以及超声下病灶形态不规则的MTC患者发生颈外侧淋巴结转移的风险较高，建议行颈外侧淋巴结清扫。

关键词： 甲状腺髓样癌; 颈外侧淋巴结转移; meta分析; 临床特征; 超声影像; 危险因素

Abstract:

Objective: To investigate risk factors of lateral cervical lymph node metastasis (LLNM) in patients with medullary thyroid carcinoma (MTC). Methods: Published studies regarding clinicopathological factors of LLNM in MTC were searched in PubMed, Web of Science, Embase, Cochrane library, Wanfang date and CNKI. Statistical analysis was performed using Stata 14.0 software. The mean and standard deviation from the sample size, range, median, and interquartile range was estimated. Odds ratio (OR) or standard mean difference (SMD) with 95% confidence interval (CI) of related factors were analyzed by fixed/random-effects models. Egger’s test and Begg’s test were applied to assess the publication bias of the literature. This study was registered with PROSPERO (CRD42021254955). Results: Fifteen studies involving 1424 patients were included in the analysis, among whom 543 cases had LLNM (38.13%). Meta-analysis revealed that an increased risk of LLNM was associated with male gender (OR=1.64, 95%CI: 1.29–2.09, Z=4.06, P<0.01), tumor diameter≥1cm (OR=5.09, 95%CI: 2.43–10.67, Z=4.31, P<0.01), multifocality (OR=2.55, 95%CI: 1.79–3.61, Z=5.22, P<0.01), capsule invasion (OR=7.80, 95%CI: 4.84–12.55, Z=8.46, P<0.01), extracapsular extension (OR=9.46, 95%CI: 5.66–15.81, Z=8.58, P<0.01), cervical central lymph node metastasis (OR=23.58, 95%CI: 9.44–58.87, Z=6.77, P<0.01), elevated preoperative calcitonin (SMD=1.17,95%CI: 0.67–1.67, Z=4.56, P<0.01), spiculated margin on ultrasonography (OR=4.32, 95%CI: 2.43–7.68, Z=4.99, P<0.01), irregular shape on ultrasonography (OR=6.81, 95%CI: 3.64–12.73, Z=6.01, P<0.01); while age ≥ 45 years (OR=1.22, 95%CI: 0.65–2.29, Z=0.62, P>0.05), elevated preoperative carcinoembryonic antigen (SMD=0.95, 95%CI: –0.48–2.38, Z=1.30, P>0.05) and calcification on ultrasonography (OR=1.28, 95%CI: 0.75–2.18, Z=0.92, P>0.05) were not associated with LLNM.Conclusion: Male gender, tumor diameter≥1?cm, multifocality, capsule invasion, extracapsular extension, central lymph node metastasis, elevated preoperative calcitonin, spiculated margin and irregular shape on ultrasonography are risk factors for LLNM in MTC, when these clinical and ultrasonic features are present, lateral neck lymph node dissection is recommended.

Key words: Medullary thyroid carcinoma Lateral cervical lymph node metastasis Meta-analysis Clinical characteristics Ultrasonic tomography Risk factor

收稿日期: 2021-07-26 出版日期: 2022-03-22

CLC:

R736.1

基金资助: 浙江省基础公益研究计划（LGF22H160082，LGF22H070008）；杭州市医药卫生科技计划（A20200432）

通讯作者: 罗定存 E-mail: ldc65@163.com

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	吴凡
	周天晗
	陆凯宁
	潘婷
	倪烨钦
	赵玲倩
	姜可成
	张煜
	罗定存

引用本文:

吴凡,周天晗,陆凯宁,潘婷,倪烨钦,赵玲倩,姜可成,张煜,罗定存. 甲状腺髓样癌患者颈外侧淋巴结转移危险因素分析[J]. 浙江大学学报（医学版）, 2021, 50(6): 730-740.

WU Fan,ZHOU Tianhan,LU Kaining,PAN Ting,NI Yeqin,ZHAO Lingqian,JIANG Kecheng,ZHANG Yu,LUO Dingcun. Risk factors for lateral cervical lymph node metastasis in medullary thyroid carcinoma. J Zhejiang Univ (Med Sci), 2021, 50(6): 730-740.

链接本文:

https://www.zjujournals.com/med/CN/10.3724/zdxbyxb-2021-0210 或 https://www.zjujournals.com/med/CN/Y2021/V50/I6/730

图 1 甲状腺髓样癌患者颈外侧淋巴结转移的临床及超声影像危险因素相关文献筛选流程图

表 1 15篇纳入文献的基线资料

图 2 各项临床和超声因素对甲状腺髓样癌患者颈外侧转移性淋巴结影响的meta分析森林图

图 3 转移性中央淋巴结、术前降钙素水平升高和术前癌胚抗原水平升高的敏感性分析结果

图 4 甲状腺髓样癌患者性别与颈外侧转移性淋巴结的meta分析漏斗图

表 2 证据质量评价及推荐强度

1	MOHAMMADI M, HEDAYATI M. A brief review on the molecular basis of medullary thyroid carcinoma[J]. Cell J, 18(4): 485-492
2	SIEGELR L, MILLERK D, JEMALA. Cancer statistics, 2018[J]CA-Cancer J Clin, 2018, 68( 1): 7-30. doi: 10.3322/caac.21442
3	SCOLLOC, BAUDINE, TRAVAGLIJ P, et al.Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer[J]J Clin Endocrinol Metab, 2003, 88( 5): 2070-2075. doi: 10.1210/jc.2002-021713
4	WELLS JR.S A, ASAS L, DRALLEH, et al.Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma[J]Thyroid, 2015, 25( 6): 567-610. doi: 10.1089/thy.2014.0335
5	MITCHELLA L, GANDHIA, SCOTT-COOMBESD, et al.Management of thyroid cancer: united kingdom national multidisciplinary guidelines[J]J Laryngol Otol, 2016, 130( S2): S150-S160. doi: 10.1017/S0022215116000578
6	MAIA A L, SIQUEIRA D R, KULCSAR M A V, et al. Diagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism[J]. Arq Bras Endocrinol Metabol, 2014, 58(7): 667-700
7	KONSTANTINIDISA, STANGM, ROMANS A, et al.Surgical management of medullary thyroid carcinoma[J]Updates Surg, 2017, 69( 2): 151-160. doi: 10.1007/s13304-017-0443-y
8	LUOD, WANX, LIUJ, et al.Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range[J]Stat Methods Med Res, 2018, 27( 6): 1785-1805. doi: 10.1177/0962280216669183
9	SHIJ, LUOD, WENGH, et al.Optimally estimating the sample standard deviation from the five‐number summary[J]Res Syn Meth, 2020, 11( 5): jrsm.1429. doi: 10.1002/jrsm.1429
10	WANX, WANGW, LIUJ, et al.Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range[J]BMC Med Res Methodol, 2014, 14( 1): 135. doi: 10.1186/1471-2288-14-135
11	逯翘楚, 付利军, 李利文, 等. 甲状腺髓样癌临床特征及颈部淋巴结转移风险因素讨论[J]. 中华内分泌外科杂志, 2019, 13(2): 139-143 LU Qiaochu, FU Lijun, LI Liwen, et al. Clinical analysis of medullary thyroid carcinoma and risk factors of cervical lymph node metastasis[J]. Chinese Journal of Endocrine Surgery, 2019, 13(2): 139-143. (in Chinese)
12	李树岭, 候秀坤, 董居来, 等. 术前临床及原发肿瘤超声影像学特征对散发性甲状腺髓样癌颈外侧淋巴结转移预测分析[J]. 中国肿瘤临床, 2019, 46(20): 1031-1035 LI Shuling, HOU Xiukun, DONG Julai, et al. Prediction of lateral cervical lymph node metastasis in patients with sporadic medullary thyroid carcinoma using preoperative clinical and ultrasonographic features[J].Chinese Journal of Clinical Oncology, 2019, 46(20): 1031-1035. (in Chinese)
13	刘鑫, 朱乔丹, 邵智颖, 等. 颈外侧部淋巴结转移与甲状腺髓样癌超声特征的相关因素分析[J]. 影像研究与医学应用, 2020, 4(17): 64-66 LIU Xin, ZHU Qiaodan, SHAO Zhiying, et al. Analysis of correlation factors between lateral cervical lymph node metastasis and ultrasound characteristics of medullary thyroid carcinoma[J]. Journal of Imaging Research and Medical Application, 2020, 4(17): 64-66. (in Chinese)
14	史亚飞, 张颖超, 樊友本, 等. 甲状腺髓样癌手术切除范围的研究[J]. 中华普通外科杂志, 2020, 35(11): 856-861 SHI Yafei, ZHANG Yingchao, FAN Youben, et al. A study on resection extent for medullary thyroid carcinoma[J]. Chinese Journal of General Surgery, 2020, 35(11): 856-861. (in Chinese)
15	MACHENSA, HOLZHAUSENH J, DRALLEH. Skip metastases in thyroid cancer leaping the central lymph node compartment[J]Arch Surg, 2004, 139( 1): 43-45. doi: 10.1001/archsurg.139.1.43
16	CHANDEZEM M, NOULLETS, FARONM, et al.Can we predict the lateral compartment lymph node involvement in ret-negative patients with medullary thyroid carcinoma?[J]Ann Surg Oncol, 2016, 23( 11): 3653-3659. doi: 10.1245/s10434-016-5292-2
17	OHH S, KWONH, SONGE, et al.Preoperative clinical and sonographic predictors for lateral cervical lymph node metastases in sporadic medullary thyroid carcinoma[J]Thyroid, 2018, 28( 3): 362-368. doi: 10.1089/thy.2017.0514
18	PENAI, CLAYMANG L, GRUBBSE G, et al.Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer[J]Head Neck, 2018, 40( 1): 79-85. doi: 10.1002/hed.24969
19	FANW, XIAOC, WUF. Analysis of risk factors for cervical lymph node metastases in patients with sporadic medullary thyroid carcinoma[J]J Int Med Res, 2018, 46( 5): 1982-1989. doi: 10.1177/0300060518762684
20	ITOY, MIYAUCHIA, KIHARAM, et al.Static prognostic factors and appropriate surgical designs for patients with medullary thyroid carcinoma: the second report from a single-institution study in Japan[J]World J Surg, 2018, 42( 12): 3954-3966. doi: 10.1007/s00268-018-4738-z
21	OPSAHLE M, AKSLENL A, SCHLICHTINGE, et al.The role of calcitonin in predicting the extent of surgery in medullary thyroid carcinoma: a nationwide population-based study in norway[J]Eur Thyroid J, 2019, 8( 3): 159-166. doi: 10.1159/000499018
22	YEL, ZHOUX, LUJ, et al.Combining serum calcitonin, carcinoembryonic antigen, and neuron‐specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma[J/OL]J Clin Lab Anal, 2020, 34( 7): e23278. doi: 10.1002/jcla.23278
23	PARKH, PARKJ, CHOIM S, et al.Preoperative serum calcitonin and its correlation with extent of lymph node metastasis in medullary thyroid carcinoma[J]Cancers, 2020, 12( 10): 2894. doi: 10.3390/cancers12102894
24	WUX, LIB, ZHENGC, et al.Risk factors for lateral lymph node metastases in patients with sporadic medullary thyroid carcinoma[J]Technol Cancer Res Treat, 2020, 153303382096208. doi: 10.1177/1533033820962089
25	SPANHEIMERP M, GANLYI, CHOUJ F, et al.Prophylactic lateral neck dissection for medullary thyroid carcinoma is not associated with improved survival[J]Ann Surg Oncol, 2021, 28( 11): 6572-6579. doi: 10.1245/s10434-021-09683-8
26	HAUGENB R, ALEXANDERE K, BIBLEK C, et al.2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]Thyroid, 2016, 26( 1): 1-133. doi: 10.1089/thy.2015.0020
27	金玲爽. 45例甲状腺髓样癌患者颈部淋巴结转移规律及术式探讨[J]. 临床耳鼻咽喉头颈外科杂志，2018, 32（19）: 1504-1506 JIN Lingshuang. The patterns of cervical lymph node metastasis and the surgical treatment for untreated medullary thyroid carcinoma[J]. Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 2018, 32(19): 1504-1506. (in Chinese)
28	XUES, HANZ, LUQ, et al.Clinical and ultrasonic risk factors for lateral lymph node metastasis in papillary thyroid microcarcinoma: a systematic review and meta-analysis[J]Front Oncol, 2020, 436. doi: 10.3389/fonc.2020.00436
29	WEI X, WANG M, WANG X, et al. Prediction of cervical lymph node metastases in papillary thyroid microcarcinoma by sonographic features of the primary site [J]. Cancer Biol Med, 2019, 16(3): 587-594
30	SCOPSIL, SAMPIETROG, BORACCHIP, et al.Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid: a retrospective study of 109 consecutive patients[J]Cancer, 1996, 78( 10): 2173-2183. doi: 10.1002/(SICI)1097-0142(19961115)78:10<2173::AID-CNCR20>3.0.CO;2-V
31	SAADM F, ORDONEZN G, RASHIDR K, et al.Medullary carcinoma of the thyroid[J]Medicine, 1984, 63( 6): 319-342. doi: 10.1097/00005792-198411000-00001
32	HADDADR I, NASRC, BISCHOFFL, et al.NCCN guidelines insights: thyroid carcinoma, version 2.2018[J]J Natl Compr Canc Netw, 2018, 16( 12): 1429-1440. doi: 10.6004/jnccn.2018.0089
33	KIMJ H, PYOJ S, CHOW J. Clinicopathological significance and prognosis of medullary thyroid microcarcinoma: a meta-analysis[J]World J Surg, 2017, 41( 10): 2551-2558. doi: 10.1007/s00268-017-4031-6
34	MACHENSA, DRALLEH. Biomarker-based risk stratification for previously untreated medullary thyroid cancer[J]J Clin Endocrinol Metab, 2010, 95( 6): 2655-2663. doi: 10.1210/jc.2009-2368

[1]	周雨梅,谢妮,张丽霞,陈丹青. 糖尿病家族史对妊娠糖尿病孕妇血糖、血脂及妊娠结局的影响[J]. 浙江大学学报（医学版）, 2021, 50(3): 329-334.
[2]	刘传霞,陈谦明. 儿童口腔黏膜糜烂溃疡类疾病的临床诊断[J]. 浙江大学学报（医学版）, 2021, 50(2): 155-161.
[3]	付媛媛,姜晶鑫,陈述政,邱福铭. T1期乳腺癌患者发生同侧腋窝淋巴结转移风险列线图的建立[J]. 浙江大学学报（医学版）, 2021, 50(1): 81-89.
[4]	彭洁,徐文飞,李旭辉,吴巧爱. 黑升麻提取物可改善子宫内膜异位症患者术后治疗的低雌激素状态[J]. 浙江大学学报（医学版）, 2020, 49(3): 397-405.
[5]	胡琳琳,张睿婷,王淑玥,洪慧,黄沛钰,张敏鸣. 心脑血管疾病高危因素对脑铁沉积影响的磁共振影像学研究[J]. 浙江大学学报（医学版）, 2019, 48(6): 644-650.
[6]	林静,陈志敏. 儿童重症腺病毒肺炎早期识别的研究进展[J]. 浙江大学学报（医学版）, 2019, 48(5): 567-572.
[7]	麦合木提江·穆扎帕,周敏. 腹主动脉瘤腔内修复术中髂内动脉封堵后盆腔缺血症状发生的危险因素[J]. 浙江大学学报（医学版）, 2019, 48(5): 546-551.
[8]	陶安阳, 王志敏, 陈红芳, 徐冬娟, 胡海芳, 吴承龙, 张晓玲, 马小董, 王亚仙, 胡海涛, 楼敏, 浙江省缺血性脑卒中静脉溶栓的临床行为干预研究协作组 . 合并心房颤动对缺血性脑卒中患者静脉溶栓后颅内出血转化的影响[J]. 浙江大学学报（医学版）, 2019, 48(3): 254-259.
[9]	陈栋,胡元军,武玉睿,李晓莺. 先天性膈疝患儿死亡危险因素分析[J]. 浙江大学学报（医学版）, 2019, 48(1): 83-88.
[10]	曹丽芹,施继敏. 异基因造血干细胞移植植入失败研究进展[J]. 浙江大学学报（医学版）, 2018, 47(6): 651-658.
[11]	李小勇,沈鹏,林鸿波,虞哲彬,陈坤,王建炳. 宁波社区2型糖尿病患者发生糖尿病肾病危险因素调查[J]. 浙江大学学报（医学版）, 2018, 47(2): 163-168.
[12]	蒋曦依,李璐,唐慧娟,陈天辉. 结直肠癌高危人群多因素风险预测模型及评价[J]. 浙江大学学报（医学版）, 2018, 47(2): 194-200.
[13]	张晓群等. 不同药物洗脱支架对冠状动脉小血管病变患者预后影响的meta分析[J]. 浙江大学学报（医学版）, 2017, 46(3): 305-314.
[14]	李文波等. 手术和非手术治疗老年人肱骨近端三、四部分骨折疗效的meta分析[J]. 浙江大学学报（医学版）, 2016, 45(6): 641-647.
[15]	韩瑞等. 贝伐珠单克隆抗体联合化疗用于Her2阴性乳腺癌患者新辅助治疗的meta分析[J]. 浙江大学学报（医学版）, 2016, 45(4): 379-386.

Viewed

Full text

Abstract

Cited

Shared

Discussed